Adult-onset Still's Disease during Pregnancy Treated with Tocilizumab
A 28-year-old woman exhibited a spiking fever, arthritis, and liver disfunction when she was 22 weeks pregnant. She was diagnosed with adult-onset Still's disease (AOSD). As her condition was resistant to corticosteroid therapy, tocilizumab (TCZ) was selected. The TCZ treatment was effective, and she delivered a healthy child while receiving TCZ treatment. Cases in which AOSD first arises during pregnancy are rare, and there have been no reports of TCZ treatment for AOSD being initiated during pregnancy. Although the safety of TCZ treatment during pregnancy has not been established, it may be effective against severe AOSD that develops during pregnancy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
---|---|
Enthalten in: |
Internal medicine (Tokyo, Japan) - 61(2022), 20 vom: 15. Okt., Seite 3137-3140 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Imaizumi, Chihiro [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adrenal Cortex Hormones |
---|
Anmerkungen: |
Date Completed 18.10.2022 Date Revised 19.11.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.2169/internalmedicine.8886-21 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM338141456 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM338141456 | ||
003 | DE-627 | ||
005 | 20231226000013.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2169/internalmedicine.8886-21 |2 doi | |
028 | 5 | 2 | |a pubmed24n1127.xml |
035 | |a (DE-627)NLM338141456 | ||
035 | |a (NLM)35283384 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Imaizumi, Chihiro |e verfasserin |4 aut | |
245 | 1 | 0 | |a Adult-onset Still's Disease during Pregnancy Treated with Tocilizumab |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.10.2022 | ||
500 | |a Date Revised 19.11.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a A 28-year-old woman exhibited a spiking fever, arthritis, and liver disfunction when she was 22 weeks pregnant. She was diagnosed with adult-onset Still's disease (AOSD). As her condition was resistant to corticosteroid therapy, tocilizumab (TCZ) was selected. The TCZ treatment was effective, and she delivered a healthy child while receiving TCZ treatment. Cases in which AOSD first arises during pregnancy are rare, and there have been no reports of TCZ treatment for AOSD being initiated during pregnancy. Although the safety of TCZ treatment during pregnancy has not been established, it may be effective against severe AOSD that develops during pregnancy | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a adult-onset Still's disease | |
650 | 4 | |a tocilizumab, pregnancy | |
650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
650 | 7 | |a tocilizumab |2 NLM | |
650 | 7 | |a I031V2H011 |2 NLM | |
700 | 1 | |a Saito, Masaya |e verfasserin |4 aut | |
700 | 1 | |a Abe, Fumito |e verfasserin |4 aut | |
700 | 1 | |a Kaga, Hajime |e verfasserin |4 aut | |
700 | 1 | |a Saito, Ayano |e verfasserin |4 aut | |
700 | 1 | |a Nara, Mizuho |e verfasserin |4 aut | |
700 | 1 | |a Kameyama, Saeko |e verfasserin |4 aut | |
700 | 1 | |a Miura, Hiroshi |e verfasserin |4 aut | |
700 | 1 | |a Ogasawara, Hitoshi |e verfasserin |4 aut | |
700 | 1 | |a Hirakawa, Takeo |e verfasserin |4 aut | |
700 | 1 | |a Mizunuma, Makito |e verfasserin |4 aut | |
700 | 1 | |a Satoh, Makiko |e verfasserin |4 aut | |
700 | 1 | |a Komatsuda, Atsushi |e verfasserin |4 aut | |
700 | 1 | |a Terada, Yukihiro |e verfasserin |4 aut | |
700 | 1 | |a Takahashi, Naoto |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Internal medicine (Tokyo, Japan) |d 1996 |g 61(2022), 20 vom: 15. Okt., Seite 3137-3140 |w (DE-627)NLM012606731 |x 1349-7235 |7 nnns |
773 | 1 | 8 | |g volume:61 |g year:2022 |g number:20 |g day:15 |g month:10 |g pages:3137-3140 |
856 | 4 | 0 | |u http://dx.doi.org/10.2169/internalmedicine.8886-21 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 61 |j 2022 |e 20 |b 15 |c 10 |h 3137-3140 |